Power to the Patients
By Brandon Li
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Brandon Li
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 54
Description
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation.
Looking for a clinical trial? Visit us at www.withpower.com
| Episode | Date |
|---|---|
|
How Neuroplasticity Is Shaping the Next Generation of Psychiatric Medicines
|
May 13, 2026 |
|
70% Remission for Postpartum Depression? The Psychedelic Breakthrough
|
Apr 30, 2026 |
|
Why Psychiatry Is Finally Breaking Free From Dopamine
|
Apr 15, 2026 |
|
Precision Medicine Got Kidney Disease Wrong—Until Now
|
Apr 01, 2026 |
|
Why Dr. Ken Sharlin Believes Most Neurological Diseases Are Reversible
|
Mar 18, 2026 |
|
Why Serotonin Isn’t Outdated, Our Thinking Is
|
Mar 11, 2026 |
|
Who Really Protects Patients in Clinical Trials? With Dr. Lara Shirikjian
|
Feb 25, 2026 |
|
Turning Pain Into Progress: How Sonia Prashar Built a Mission Around Mental Health
|
Feb 18, 2026 |
|
The Synapse Secret: How One Molecule Normalized Brain Activity in Fragile X Patients
|
Feb 11, 2026 |
|
Beyond Dopamine: Why Traditional Schizophrenia Treatments Miss 50% of Patient Needs
|
Feb 04, 2026 |
|
The 20-Year Industry Secret: Redefining Neurodegenerative Treatment
|
Jan 09, 2026 |
|
One Mechanism, Three Conditions: A New Direction in Neurological Treatment
|
Dec 03, 2025 |
|
Why Traditional Psychedelics Miss 90% of Neurology Patients - And The Solution
|
Nov 12, 2025 |
|
Inside the ALS Breakthrough: 20-Year Journey to FDA Approval with Dr. Joseph Palumbo
|
Nov 05, 2025 |
|
Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan
|
Oct 21, 2025 |
|
Dr. Anantha Shekhar on the Convergence of Psychiatry, Neurology, and the Next Era of Brain Medicine
|
Oct 15, 2025 |
|
Ram Mukunda, CEO of IGC Pharma, on Innovation and Hope in Alzheimer’s Care
|
Sep 23, 2025 |
|
Brandon Bentzley, CSO and Co-founder of Magnus Medical, on Precision Psychiatry and Rewiring Depression
|
Sep 17, 2025 |
|
Sarah MacCallum & Melissa Gaines- Clinical Operations Leaders at Annovis Bio
|
Sep 10, 2025 |
|
Daniel O'Connell, CEO of Acumen Pharmaceuticals, on Oligomers, Innovation, and Hope in Alzheimer’s
|
Sep 05, 2025 |
|
Michael Gold, Chief R&D Officer at Compass Pathways
|
Aug 26, 2025 |
|
Matthew Leoni, CMO of Merida Biosciences, on Navigating the Challenges and Opportunities in Neuroscience Drug Development
|
Aug 14, 2025 |
|
Gerard Sanacora, Professor at Yale, on glutamate, GABA, and the next era of depression treatment
|
Jun 19, 2025 |
|
Backing Breakthroughs in Psychedelics
|
Jun 06, 2025 |
|
Joel Raskin, CMO of Arrivo Bio talks about unlocking the future of psychiatry
|
May 23, 2025 |
|
Dr. Jerry Rosenbaum & Dr. Sharmin Ghaznavi: Mass General Center on the Neuroscience of Psychedelics
|
May 12, 2025 |
|
Spyros Papapetropoulos, CEO of Neuphoria
|
May 12, 2025 |
|
Steve Gourlay, CEO of Actinogen
|
Apr 28, 2025 |
|
Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry
|
Apr 09, 2025 |
|
John Krystal: Advancing Ketamine Research & Psychiatry at Yale
|
Mar 07, 2025 |
|
Next-Gen Treatments for Anxiety and Depression Disorders
|
Feb 25, 2025 |
|
Precision Psychiatry and Emerging Technologies
|
Feb 21, 2025 |
|
From Culture to Care: The Framework of Patient Centricity
|
Feb 07, 2025 |
|
Unraveling Mysteries of the Brain Through Neuroscience Research
|
Feb 05, 2025 |
|
Harnessing Precision Medicine to Redefine Psychiatric Treatment
|
Jan 29, 2025 |
|
Breaking New Ground with Psilocybin
|
Jan 21, 2025 |
|
Bringing the Consumer Experience to Clinical Research
|
Dec 19, 2024 |
|
A New Frontier of Psychedelic Therapies
|
Dec 12, 2024 |
|
A Pragmatic Approach to Psychedelic Drug Development
|
Dec 06, 2024 |
|
Building a High Recruiting Site in Alzheimer's
|
Oct 31, 2024 |
|
Why Beckley Psytech is Developing the Next Generation of Psychedelics
|
Oct 09, 2024 |
|
The Mental Health Epidemic in Rural America
|
Oct 03, 2024 |
|
Going All In on Psilocybin for Depression
|
Sep 26, 2024 |
|
Psychedelics and the Future of Anxiety Relief
|
Sep 19, 2024 |
|
AliveAndKickn: Raising Awareness about Lynch Syndrome
|
Jun 14, 2024 |
|
Empowering Patients through Digital Platforms in Clinical Trials with Sasha Sinclair
|
May 07, 2024 |
|
Integrating Patient Experience in Clinical Trials with Farah Meghji
|
Jan 25, 2024 |
|
Patient-first Approaches in Clinical Trials with Megan Liles
|
Dec 27, 2023 |
|
Patient-informed clinical trial development with Victoria DiBiaso, VP & Global Head Patient Informed Development & Health Value Translation at Sanofi
|
Dec 11, 2023 |
|
Integrating patient centricity culturally and operationally, with Dr. Anthony Yanni, Sr. VP and Head of Patient Centricity at Astellas
|
Nov 21, 2023 |
|
Exploring Technology and Patient Engagement in Clinical Trials with Bryan Wylie
|
Oct 17, 2023 |
|
Patient advocacy with Stephanie E. Saville, Foundation Manager for the Pediatric Retinal Research Foundation
|
Oct 11, 2023 |
|
Oncology trial strategy with Deb Kientop, VP Clinical Operations at Deka Biosciences
|
Oct 03, 2023 |
|
Patient-centered design with Scott Schliebner, former SVP at ICON
|
Sep 27, 2023 |